àÍ¡ÊÒÃÍéÒ§ÍÔ§
1. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998; 47:1-14.
2. Kulwichit W. Postexposure prophylaxis of HIV infection in health care workers. In: Ruxrungtham K, ed. HIV/AIDS: Clinical and Clinical Research. Bangkok: Chuanpim Publishing, Ltd., 1998:266-293.
3. Bamberger JD, Waldo CR, Gerberding JL, Katz MH. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. Am J Med 1999; 106:323-6.
4. Merchant RC. Nonoccupational HIV postexposure prophylaxis: a new role for the emergency department. Ann Emerg Med 2000; 36:366-75.
5. Henderson DK. HIV postexposure prophylaxis in the 21st century. Emerg Infect Dis 2001; 7:254-8.
6. Moran GJ. Emergency department management of blood and body fluid exposures. Ann Emerg Med 2000; 35:47-62.
7. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 2002; 51: 1-56.
8. Hoofnagle JH, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 1991; 11:73-83.
9. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Morb Mortal Wkly Rep 2001; 50:1-52.
10. Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev 2000; 13:385-407.
11. Theamboonlers A, Tangkijvanich P, Jantaradsamee P, Hirsch P, Poovorawan Y. Prevalence of core promotor and precore mutants of hepatitis B virus in thailand by RFLP and sequencing. Southeast Asian J Trop Med Public Health 1999; 30:750-5.
12. Cancio-Bello TP, de Medina M, Shorey J, Valledor MD, Schiff ER. An institutional outbreak of hepatitis B related to a human biting carrier. J Infect Dis 1982; 146:652-6.
13. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1:550-1.
14. Snydman DR, Bryan JA, Macon EJ, Gregg MB. Hemodialysis-associated hepatitis: report of an epidemic with further evidence on mechanisms of transmission. Am J Epidemiol 1976; 104:563-70.
15. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR Morb Mortal Wkly Rep 1989; 38 Suppl 6:1-37.
16. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1997; 46:1-42.
17. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Recomm Rep 1991; 40:1-9.
18. NHS Executive. Hepatitis B infected health care workers: guidance on implementation of health service circular 2000/020. Department of Health. London, 2000:1-11. URL: http://www.doh.gov.uk/nhsexec/hepatitisb.htm accessed on August 10, 2002.
19. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. The Incident Investigation Teams and others. N Engl J Med 1997; 336:178-84.
20. Sundkvist T, Hamilton GR, Rimmer D, Evans BG, Teo CG. Fatal outcome of transmission of hepatitis B from an e antigen negative surgeon. Commun Dis Public Health 1998; 1:48-50.
21. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
22. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. MMWR Morb Mortal Wkly Rep 1997; 46:603-6.
23. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327:1899-905.
24. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998; 47:1-39.
25. Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16:1109-14.
26. Hsu HH, Wright TL, Luba D, et al. Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology 1991; 14:763-7.
27. Dusheiko GM, Smith M, Scheuer PJ. Hepatitis C virus transmitted by human bite. Lancet 1990; 336:503-4.
28. Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis 1993; 25:270-1.
29. Ippolito G, Puro V, Petrosillo N, De Carli G, Micheloni G, Magliano E. Simultaneous infection with HIV and hepatitis C virus following occupational conjunctival blood exposure. JAMA 1998; 280:28.
30. Knodell RG, Conrad ME, Ginsberg AL, Bell CJ. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post- transfusion hepatitis. Lancet 1976; 1:557-61.
31. Seeff LB, Zimmerman HJ, Wright EC, et al. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology 1977; 72:111-21.
32. Sanchez-Quijano A, Pineda JA, Lissen E, et al. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1988; 1:1245-9.
33. Krawczynski K, Alter MJ, Tankersley DL, et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis 1996; 173:822-8.
34. Everhart JE, Di Bisceglie AM, Murray LM, et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 1990; 112:544-5.
35. Brown P. Surgeon infects patient with hepatitis C. BMJ 1999; 319:1219.
36. Cody SH, Nainan OV, Garfein RS, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med 2002; 162:345-50.
37. Ross RS, Viazov S, Thormahlen M, et al. Risk of hepatitis C virus transmission from an infected gynecologist to patients: results of a 7-year retrospective investigation. Arch Intern Med 2002; 162:805-10.
38. Fiser WP, Jr. Should surgeons be tested for blood-borne pathogens? Infect Control Hosp Epidemiol 2002; 23:296-7.
39. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001; 345:1452-7.
40. Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers. Italian Multicenter Study. The Italian Study Group on Occupational Risk of HIV infection. Arch Intern Med 1993; 153:1451-8.
41. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood--France, United Kingdom, and United States, January 1988-August 1994. MMWR Morb Mortal Wkly Rep 1995; 44:929-33.
42. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997; 337:1485-90.
43. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998; 47:1-33.
44. Mast ST, Woolwine JD, Gerberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J Infect Dis 1993; 168:1589-92.
45. Bennett NT, Howard RJ. Quantity of blood inoculated in a needlestick injury from suture needles. J Am Coll Surg 1994; 178:107-10.
46. Discussion: To what extent do these data indicate that postexposure prophylaxis with zidovudine is effective in humans? Am J Med 1997; 102:56-57.
47. Henderson DK. Postexposure treatment of HIV--taking some risks for safety's sake. N Engl J Med 1997; 337:1542-3.
48. Weiss SH. Risks and issues for the health care worker in the human immunodeficiency virus era. Med Clin North Am 1997; 81:555-75.
49. Manion DJ, Hirsch MS. Combination chemotherapy for human immunodeficiency virus-1. Am J Med 1997; 102:76-80; discussion 81-2.
50. Jochimsen EM. Failures of zidovudine postexposure prophylaxis. Am J Med 1997; 102:52-5; discussion 56-7.
51. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR Morb Mortal Wkly Rep 1996; 45:468-80.
52. Puro V. Post-exposure prophylaxis for HIV infection. Italian Registry of Post- Exposure Prophylaxis. Lancet 2000; 355:1556-7.
53. Parkin JM, Murphy M, Anderson J, El-Gadi S, Forster G, Pinching AJ. Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet 2000; 355:722-3.
54. Departments UH. HIV Post-Exposure Prophylaxis: Guidance from the UK Chief Medical Officers’ Expert Advisory Group on AIDS, 2000:1-34.
55. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000. MMWR Morb Mortal Wkly Rep 2001; 49:1153-6.
56. Johnson S, Baraboutis JG. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA 2000; 284:2722-3.
57. Benn PD, Mercey DE, Brink N, Scott G, Williams IG. Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1. Lancet 2001; 357:687-8.
58. Johnson S, Chan J, Bennett CL. Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Ann Intern Med 2002; 137:146-7.
59. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999; 354:1084-9.
60. Bristol-Myers Squibb Company. Healthcare Provider Important Drug Warning Letter., January 5, 2001.
61. Gold Standard Multimedia Inc. Efavirenz. In: Clinical Pharmacology 2000. Updated 2002.
62. Fundaro C, Genovese O, Rendeli C, Tamburrini E, Salvaggio E. Myelomeningocele in a child with intrauterine exposure to efavirenz. AIDS 2002; 16:299-300.
63. De Santis M, Carducci B, De Santis L, Cavaliere AF, Straface G. Periconceptional exposure to efavirenz and neural tube defects. Arch Intern Med 2002; 162:355.
64. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Pharmacologic Considerations in HIV-infected Pregnant Patients. A Guide to the Clinical Care of Women with HIV, 2001:401-470.
65. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 2001; 50:1-52.
66. Robert LM, Chamberland ME, Cleveland JL, et al. Investigations of patients of health care workers infected with HIV. The Centers for Disease Control and Prevention database. Ann Intern Med 1995; 122:653-7.
67. Jaffe HW, McCurdy JM, Kalish ML, et al. Lack of HIV transmission in the practice of a dentist with AIDS. Ann Intern Med 1994; 121:855-9.
68. Update: transmission of HIV infection during invasive dental procedures- -Florida. MMWR Morb Mortal Wkly Rep 1991; 40:377-81.
69. Update--transmission of HIV infection during an invasive dental procedure--Florida. MMWR Morb Mortal Wkly Rep 1991; 40:21-7, 33.
70. Recommended infection-control practices for dentistry, 1993. Centers for Disease Control and Prevention. MMWR Recomm Rep 1993; 42:1-12.
71. McNearney T, Westervelt P, Thielan BJ, et al. Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak. Proc Natl Acad Sci U S A 1990; 87:1917-21.
72. Barr S. The 1990 Florida Dental Investigation: is the case really closed? Ann Intern Med 1996; 124:250-4.
73. Dorozynski A. French patient contracts AIDS from surgeon. BMJ 1997; 314:250.
74. Lot F, Seguier JC, Fegueux S, et al. Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med 1999; 130:1-6.
75. Blanchard A, Ferris S, Chamaret S, Guetard D, Montagnier L. Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients. J Virol 1998; 72:4537-40.
76. Gerberding J. Provider-to-patient HIV transmission: how to keep it exceedingly rare. Ann Intern Med 1999; 130:64-5.